Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

被引:0
|
作者
Basli, Abdelkader [1 ,2 ]
Bounaas, Jihane [1 ]
机构
[1] Univ Skikda, Fac Sci, Lab Interact Res Biodivers Ecosyst & Biotech, Skikda, Algeria
[2] Univ August 20 1955, 1955 BP 26,Rd El Hadaiek, Skikda 21000, Algeria
关键词
Alzheimer's disease; amyloid beta; tau protein; novel therapies; AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-E; TAU-PROTEIN; NITRIC-OXIDE; POSTTRANSLATIONAL MODIFICATIONS; GAMMA-SECRETASE; PHOSPHORYLATION; PEROXYNITRITE; AGGREGATION; INHIBITION;
D O I
10.1177/02601060221137104
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Alzheimer's disease (AD) is characterized by the presence of two types of protein deposits in the brain, amyloid plaques and neurofibrillary tangles. The first one are dense deposits of beta amyloid protein, the second one are dense deposits of the protein tau. These proteins are present in all of our brains, but in AD they act unusually, leading to neuronal degeneration. This review will provide an overview of the AD, including the role of amyloid beta and tau, and mechanisms that lead to the formation of plaques and tangles. The review will also cover the existing researches that have focused on the inhibition of amyloid beta formation, cholinesterase, tau hyperphosphorylation, the pathogenic mechanisms of apoE4, and GSK-3 as a solution that could be used to slow or prevent the disease.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 50 条
  • [21] Alzheimer's disease therapeutic strategies
    Alfredo, Sanabria-Castro
    Ileana, Alvarado-Echeverria
    Cecilia, Monge-Bonilla
    ENEUROBIOLOGIA, 2016, 7 (15):
  • [22] Therapeutic strategies for Alzheimer's disease
    Barten, Donna M.
    Albright, Charles F.
    MOLECULAR NEUROBIOLOGY, 2008, 37 (2-3) : 171 - 186
  • [23] Advances in developing therapeutic strategies for Alzheimer's disease
    Nguyen, Thuy Trang
    Nguyen, Thi Thuy Dung
    Nguyen, Thi Kim Oanh
    Vo, Tuong Kha
    Vo, Van Giau
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [24] A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease
    Kumar, Manish
    Bansal, Nitin
    CURRENT DRUG TARGETS, 2022, 23 (05) : 486 - 512
  • [25] Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
    Simic, Goran
    Leko, Mirjana Babic
    Wray, Selina
    Harrington, Charles
    Delalle, Ivana
    Jovanov-Milosevic, Natasa
    Bazadona, Danira
    Buee, Luc
    de Silva, Rohan
    Di Giovanni, Giuseppe
    Wischik, Claude
    Hof, Patrick R.
    BIOMOLECULES, 2016, 6 (01) : 2 - 28
  • [26] Therapeutic Effects of Natural Drugs on Alzheimer's Disease
    Ma, Yuan
    Yang, Man-wen
    Li, Xin-wei
    Yue, Jian-wei
    Chen, Jun-zong
    Yang, Mei-wen
    Huang, Xuan
    Zhu, Lian-lian
    Hong, Fen-fang
    Yang, Shu-long
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [27] Alzheimer's disease: Recent treatment strategies
    Vaz, Miguel
    Silvestre, Samuel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 887
  • [28] Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer's Disease
    Zhou, Qiuzhi
    Wang, Weixia
    Deng, Chunchu
    MOLECULAR NEUROBIOLOGY, 2025,
  • [29] Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease
    Inamdar, Aparna
    Gurupadayya, Bannimath
    Halagali, Prashant
    Nandakumar, S.
    Pathak, Rashmi
    Singh, Himalaya
    Sharma, Himanshu
    CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (08) : 598 - 618
  • [30] Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis
    Plascencia-Villa, German
    Perry, George
    ANTIOXIDANTS & REDOX SIGNALING, 2021, 34 (08) : 591 - 610